Thu, 23 May, 2024

NARF: Clinical Trial Update

We are delighted to announce that the Natasha Clinical Trial has released its first update, and the initial results are promising.

The Natasha Clinical Trial uses daily doses of everyday food products, taken under strict medical supervision, rather than expensive pharmaceuticals to train the bodies of children and young people to tolerate the foods that cause them a severe allergic reaction.

The four key updates are:

Natasha’s parents Nadim and Tanya Ednan-Laperouse, who have both been awarded OBEs for their services to charity and people with allergies, are delighted with how the trial is progressing. Tanya said: “This is a major first step in our mission to make food allergies history.”

Sibel Sonmez-Ajtai, Paediatric Allergy Consultant and Principal Investigator at Sheffield Children’s Hospital, one of the centres involved in the trial, said: “This study is enabling us to do something we would never have dreamed of doing before – giving patients the foods we know they are allergic to! This treatment is not a cure for a food allergy, but what it achieves is life transforming. To have a patient who has had anaphylaxis to 4mls of milk to then tolerate 90mls within six to eight months is nothing less than a miracle.”

We are delighted with the first update of the trial and will continue to support Natasha’s Allergy Research Foundation to #makeallergyhistory – keep your eyes peeled for a fundraising announcement coming this week!

Donate here.

Share the post:

Related Stories

Other News & Insights